Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2010
07/14/2010EP2205591A1 Novel polymorphs of bosentan
07/14/2010EP2205583A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists
07/14/2010EP2205564A1 Novel kinase inhibitors
07/14/2010EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
07/14/2010EP2205559A1 Renin inhibitors
07/14/2010EP2205278A1 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors
07/14/2010EP1966218B1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases
07/14/2010EP1696900B1 Use of treprostinil to treat ischemic lesions
07/14/2010EP1636224B1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
07/14/2010EP1490030B2 Nanoparticulate compositions of angiogenesis inhibitors
07/14/2010EP1486494B1 N-substituted benzothiophenesulfonamide derivative
07/14/2010EP1383551B1 Multilumen catheter and implants for the delivery of therapeutic agents to tissues
07/14/2010EP1222226B1 Highly-neutralized ethylene copolymers and their use in golf balls
07/14/2010CN1935235B Chinese medicine injection preparation and its preparing method
07/14/2010CN1935176B Method for preparing red flower extract containing total red flower uranidin
07/14/2010CN101778842A A process for the preparation or purification of olmesartan medoxomil
07/14/2010CN101775406A Recombinant protein expression and purification with functions of preventing and treating atherosclerosis
07/14/2010CN101775348A Health-care vinegar, brewing method and application in preventing cardiovascular diseases thereof
07/14/2010CN101775072A Glial cell line-Derived Neurotrophic Factor (GDNF) fusing penetrating peptides
07/14/2010CN101775063A Saponins compound and application thereof
07/14/2010CN101774994A Chrysin long-chain derivative as well as preparation method and purpose thereof
07/14/2010CN101774969A Ivabradine sulfate and method for preparing type I crystal thereof
07/14/2010CN101773669A HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
07/14/2010CN101773658A medicine containing indapamide
07/14/2010CN101773657A Medicine containing sodium nitroprusside
07/14/2010CN101773640A Drug for treatment of myocarditis
07/14/2010CN101773616A Drug for treatment of coronary arteriosclerotic cardiopathy
07/14/2010CN101773614A Drug for treatment of rheumatic heart disease
07/14/2010CN101773613A Drug for treatment of rheumatic heart disease
07/14/2010CN101773611A Brain-clearing and heart-nourishing liquor
07/14/2010CN101773610A Drug for treatment of hypertension
07/14/2010CN101773595A Herbal tea for clearing liver and improving eyesight
07/14/2010CN101773591A Medicine for activating blood, removing stasis and treating stroke
07/14/2010CN101773590A Chinese drug capsule for treatment of coronary heart disease with qi deficiency and blood stasis
07/14/2010CN101773586A Drug for treatment of coronary heart disease
07/14/2010CN101773584A Flavonoid extract containing schaftoside and application thereof
07/14/2010CN101773579A Chinese medicine for treating hemorrhoids and constipation
07/14/2010CN101773576A Drug for treatment of hypertension
07/14/2010CN101773574A Chinese herbal medicine powder cooperating with bath chair to treat haemorrhoids and preparation method thereof
07/14/2010CN101773566A Drug for treatment of myocarditis
07/14/2010CN101773564A Method for extracting alkaloid from Semen hoveniae and method for purifying Semen hoveniae alkaloid
07/14/2010CN101773563A Medicine composition
07/14/2010CN101773562A Method for identifying components of capsule medicine for treating hemorrhoids
07/14/2010CN101773554A Medicine for treating high blood pressure and preparation method thereof
07/14/2010CN101773552A Gangrene ointment, and qi-tonifying, blood-circulation-invigorating and detoxifying yin, and yang-warming and pulse-beat-invigorating yin, and qi-regulating and blood-enriching yin
07/14/2010CN101773547A Quantitative determination method of effective ingredient in Salvia miltiorrhiza Bunge injecta
07/14/2010CN101773546A Salvia miltiorrhiza effective-component synchronous site-specific drug delivery mini-pill and preparation method thereof
07/14/2010CN101773544A Medicinal preparation for treating anorectal disease and preparation method thereof
07/14/2010CN101773535A External application Chinese medicine composition for treating hemorrhoids and preparation method thereof
07/14/2010CN101773533A Indoor combination method of aromatic Chinese medicinal herb plants for improving hypertensive symptom
07/14/2010CN101773529A Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation thereof
07/14/2010CN101773528A Preparation method of total terpene lactones with low phenolic acid
07/14/2010CN101773523A Traditional Chinese medicine antimanic drug for treatment of hyperlipemia and preparation thereof
07/14/2010CN101773517A H2S or H2S donator temperature sensitivity instant gel preparation for injection
07/14/2010CN101773508A Stable Trifusal pharmaceutical composition
07/14/2010CN101773500A Antihypertensive medicinal composition
07/14/2010CN101773494A New application of green tea polyphenol
07/14/2010CN101773493A New application of medicine compound brazilein
07/14/2010CN101773485A Sustained-release preparation using S-metoprolol and dihydropyridine calcium channel blocker as active components and preparation method and use thereof
07/14/2010CN101773482A Three-stage pulsed release controlled release tablet and preparation method thereof
07/14/2010CN101773476A Preparation method for laver antihypertensive peptide particles
07/14/2010CN101773465A Polymer micelle medicine carrying system using amino acid as stabilizing agent
07/14/2010CN101773349A Anion multifunctional pillow
07/14/2010CN101773179A Health-caring tea for preventing cardiovascular and cerebrovascular diseases and preparation method thereof
07/14/2010CN101574324B Felodipine sustained-release tablet and method for controlling sustained-release of Felodipine sustained-release tablet
07/14/2010CN101554439B Traditional Chinese medicine preparation for preventing cerebral arteriosclerosis
07/14/2010CN101543567B Chinese medicinal preparation for treating cerebral thrombosis
07/14/2010CN101518618B Traditional Chinese medicine preparation for treating myocardial infarction
07/14/2010CN101314620B Singular polysaccharide of lactobacillus casei exocellular polysaccharide, preparation and application thereof
07/14/2010CN101297791B Alprostadil composition and preparation thereof
07/14/2010CN101229157B Calldesartan ci1exetil medicine compounds
07/14/2010CN101036642B Ginkgolide B nanometric liposomes medicine and the preparing method thereof
07/14/2010CN101007992B Health white spirit containing beneficial functional component
07/13/2010US7756643 Method for determining the biological effect and/or activity of at least one drug, chemical substances and/or pharmaceutical composition based on their effect on the methylation status of DNA
07/13/2010US7756559 Device for generating a detectable signal based upon antibody/antigen interaction
07/13/2010US7754856 Human sodium-dependent bile acid transporter proteins
07/13/2010US7754751 Preferential inhibition of release of pro-inflammatory cytokines
07/13/2010US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12)
07/13/2010US7754748 Method for treating obesity
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754716 vatalanib succinate (PTK787) and temozolomide; glioblastomas
07/13/2010US7754692 Treating retinopathy both of diabetes and prematurity, or tumor growth
07/13/2010US7754682 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
07/13/2010US7754422 Method of judging inflammatory disease
07/13/2010US7754240 Solid at ambient temperature, softening point of </= 35 degrees C., when placed in continuous contact with skin it is softened to a consistency so substantial application of the unit dose is delivered in < 10 minutes
07/13/2010US7754228 Cytotoxic T-cell epitopes from Chlamydia
07/13/2010US7754217 HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
07/13/2010US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient
07/13/2010CA2608018C Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
07/13/2010CA2534006C Use of angiotensin ii receptor antagonists
07/13/2010CA2505910C Imidazoquinoline derivatives as adenosine a3 receptor ligands
07/13/2010CA2500888C Isoquinoline compounds and medicinal use thereof
07/13/2010CA2481365C Occlusive composition comprising a poly (2-cyanoacrylate) monomer
07/13/2010CA2448303C Biologically active methylene blue derivatives
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2443135C Pharmaceutically active compounds and methods of use
07/13/2010CA2432145C Glucopyranosyloxypyrazole derivatives and use thereof in medicines
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
1 ... 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 ... 1595